TSCWX
Price
$17.26
Change
-$0.03 (-0.17%)
Updated
May 22 closing price
Net Assets
3.23B
VSCPX
Price
$313.49
Change
-$0.20 (-0.06%)
Updated
May 22 closing price
Net Assets
139.54B
Interact to see
Advertisement

TSCWX vs VSCPX

Header iconTSCWX vs VSCPX Comparison
Open Charts TSCWX vs VSCPXBanner chart's image
Nuveen Quant Small Cap Equity W
Price$17.26
Change-$0.03 (-0.17%)
VolumeN/A
Net Assets3.23B
Vanguard Small Cap Index InstlPlus
Price$313.49
Change-$0.20 (-0.06%)
VolumeN/A
Net Assets139.54B
TSCWX vs VSCPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TSCWX vs. VSCPX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TSCWX is a Buy and VSCPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 140B vs. TSCWX (3.23B). VSCPX (1.58) and TSCWX (1.58) have matching dividends . TSCWX was incepted earlier than VSCPX: TSCWX (7 years) vs VSCPX (14 years). TSCWX (0.41) is less costly to investors than VSCPX (0.03). TSCWX is a more actively managed with annual turnover of: 78.00 vs. VSCPX (13.00). TSCWX has a lower initial minimum investment than VSCPX: TSCWX (0) vs VSCPX (100000000). VSCPX annual gain was more profitable for investors over the last year : 1.77 vs. TSCWX (-6.19). VSCPX return over 5 years is better than : 67.55 vs. TSCWX (41.30).
TSCWXVSCPXTSCWX / VSCPX
Total Expense Ratio0.000.03-
Annual Report Gross Expense Ratio0.410.031,367%
Fund Existence7 years14 years-
Gain YTD-5.571-5.530101%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.23B140B2%
Annual Yield % from dividends1.581.58100%
Returns for 1 year-6.191.77-349%
Returns for 3 years13.3122.3760%
Returns for 5 years41.3067.5561%
Returns for 10 yearsN/A91.30-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TMDX123.342.03
+1.67%
TransMedics Group
PKST11.960.01
+0.08%
Peakstone Realty Trust
SNN28.72N/A
N/A
Smith & Nephew plc
TOI2.67N/A
N/A
Oncology Institute (The)
LGHL2.71-0.08
-2.87%
Lion Group Holding Ltd